Rodman & Renshaw Upgrades ABIOMED (ABMD) to Market Perform
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw upgraded ABIOMED (NASDAQ: ABMD) from Market Underperform to Market Perform.
For more ratings news on ABIOMED click here and for the rating history of ABIOMED click here.
Shares of ABIOMED closed at $11.66 yesterday.
For more ratings news on ABIOMED click here and for the rating history of ABIOMED click here.
Shares of ABIOMED closed at $11.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
- Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
